Pacific Financial Statements From 2010 to 2026

Pacific Biosciences Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Common Stock Shares Outstanding 315 M 300 M 150.7 M Slightly volatile Total Assets 601.2 M 784.1 M 590.2 M Slightly volatile Short and Long Term Debt Total 797.4 M 759.5 M 312.3 M Slightly volatile Other Current Liabilities 27.1 M 33.6 M 27.1 M Slightly volatile Total Current Liabilities 52.5 M 54.4 M 51.9 M Slightly volatile Other Liabilities 2.8 M 3 M 19.7 M Pretty Stable Property Plant And Equipment Net 38.4 M 65.8 M 38.1 M Slightly volatile Current Deferred Revenue 11.3 M 15.9 M 11 M Slightly volatile Accounts Payable 21.8 M 20.8 M 9.1 M Slightly volatile Cash 293.5 M 279.5 M 125.5 M Slightly volatile Non Current Assets Total 264.6 M 409.1 M 269.1 M Slightly volatile Non Currrent Assets Other 6.1 M 8.8 M 6.2 M Slightly volatile Other Assets 1.09 1.15 5.2 M Very volatile Cash And Short Term Investments 292.1 M 279.5 M 276.2 M Slightly volatile Short Term Investments 404 M 384.7 M 202.8 M Slightly volatile Liabilities And Stockholders Equity 601.2 M 784.1 M 590.2 M Slightly volatile Non Current Liabilities Total 760.5 M 724.3 M 336.2 M Slightly volatile Other Current Assets 5.7 M 10.8 M 5.6 M Slightly volatile Other Stockholder Equity 5.1 M 5.3 M 1.1 B Slightly volatile Total Liabilities 817.7 M 778.7 M 388.3 M Slightly volatile Property Plant And Equipment Gross 155.2 M 147.8 M 59 M Slightly volatile Total Current Assets 336.6 M 375 M 321 M Slightly volatile Short Term Debt 7.5 M 11.5 M 7.5 M Slightly volatile Property Plant Equipment 98.2 M 93.5 M 42.3 M Slightly volatile Long Term Debt 781.8 M 744.6 M 345.1 M Slightly volatile Net Receivables 37.2 M 35.4 M 15.6 M Slightly volatile Common Stock Total Equity 189 K 198.9 K 38.1 M Slightly volatile Inventory 26.7 M 49.3 M 24.4 M Slightly volatile Common Stock 5.1 M 5.3 M 79 M Slightly volatile Long Term Debt Total 1.1 B 1 B 446.1 M Slightly volatile Deferred Long Term Liabilities 11.9 M 16.9 M 12.1 M Slightly volatile Non Current Liabilities Other 21 M 22.1 M 37.1 M Slightly volatile Capital Surpluse 1.2 B 2.3 B 1.2 B Slightly volatile Short and Long Term Debt 418.9 K 441 K 9.2 M Slightly volatile Net Invested Capital 711.6 M 1.3 B 465.4 M Slightly volatile Net Working Capital 468 M 493.8 M 286.8 M Slightly volatile Capital Stock 236.5 K 338.1 K 192.9 K Slightly volatile Capital Lease Obligations 34.9 M 22.4 M 43 M Slightly volatile
Pacific Biosciences Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 530.2 M 504.9 M 71.6 M Slightly volatile Total Revenue 84.1 M 160 M 90.2 M Slightly volatile Gross Profit 30.2 M 50.7 M 32.3 M Slightly volatile Other Operating Expenses 753.4 M 717.6 M 292.6 M Slightly volatile Research Development 90.7 M 97.3 M 84.2 M Slightly volatile Total Operating Expenses 638.6 M 608.2 M 231.1 M Slightly volatile Cost Of Revenue 73 M 109.3 M 61.5 M Slightly volatile Selling General Administrative 211.3 M 201.3 M 94.5 M Slightly volatile Interest Income 2.3 M 2.3 M 2.7 M Slightly volatile Reconciled Depreciation 64.4 M 61.4 M 18.9 M Slightly volatile Non Recurring 24.9 M 28 M 30.6 M Slightly volatile
Pacific Biosciences Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Stock Based Compensation 85.8 M 81.7 M 36.7 M Slightly volatile Begin Period Cash Flow 102.8 M 56.1 M 100.2 M Slightly volatile Depreciation 64.4 M 61.3 M 18.1 M Slightly volatile Capital Expenditures 2.6 M 2.7 M 5.1 M Pretty Stable End Period Cash Flow 103.9 M 63.7 M 93.1 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 3.33 3.5057 11.5621 Pretty Stable Days Sales Outstanding 45.54 80.8632 56.254 Slightly volatile Stock Based Compensation To Revenue 0.67 0.7 0.4193 Slightly volatile Capex To Depreciation 0.13 0.116 0.6643 Slightly volatile Inventory Turnover 2.96 2.2183 2.6234 Pretty Stable Days Of Inventory On Hand 163 165 156 Pretty Stable Payables Turnover 8.45 5.2639 7.5338 Pretty Stable Sales General And Administrative To Revenue 0.88 0.93 1.8999 Slightly volatile Research And Ddevelopement To Revenue 0.58 0.6081 1.476 Slightly volatile Capex To Revenue 0.0161 0.017 0.1415 Slightly volatile Cash Per Share 1.57 1.6512 9.7985 Slightly volatile Days Payables Outstanding 56.82 69.3404 53.8036 Pretty Stable Income Quality 0.19 0.2035 0.7331 Slightly volatile Intangibles To Total Assets 0.38 0.4246 0.4274 Slightly volatile Current Ratio 8.94 6.8919 7.6515 Pretty Stable Receivables Turnover 7.95 4.5138 7.2768 Slightly volatile Capex Per Share 0.0086 0.009 0.2722 Slightly volatile Revenue Per Share 0.84 0.5334 0.8189 Slightly volatile Interest Debt Per Share 2.68 2.5551 1.4269 Slightly volatile Debt To Assets 1.02 0.9686 0.3104 Slightly volatile Graham Number 2.28 2.57 2.8018 Slightly volatile Operating Cycle 157 245 194 Pretty Stable Days Of Payables Outstanding 56.82 69.3404 53.8036 Pretty Stable Long Term Debt To Capitalization 1.04 0.9924 0.3906 Slightly volatile Quick Ratio 8.39 5.9862 7.1076 Pretty Stable Net Income Per E B T 0.73 1.0006 0.7395 Slightly volatile Cash Ratio 4.22 5.1365 3.2745 Slightly volatile Cash Conversion Cycle 118 176 146 Pretty Stable Days Of Inventory Outstanding 163 165 156 Pretty Stable Days Of Sales Outstanding 45.54 80.8632 56.254 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 1.17 1.0244 1.0636 Pretty Stable Fixed Asset Turnover 2.34 2.4302 3.2342 Pretty Stable Debt Ratio 1.02 0.9686 0.3104 Slightly volatile Price Sales Ratio 3.33 3.5057 11.5621 Pretty Stable Asset Turnover 0.22 0.2041 0.3021 Pretty Stable Gross Profit Margin 0.28 0.3167 0.3471 Very volatile
Pacific Biosciences Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 3.9 B 3.7 B 3.9 B Slightly volatile

Pacific Fundamental Market Drivers

Pacific Upcoming Events

About Pacific Biosciences Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Pacific Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pacific Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pacific Biosciences Of Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pacific Biosciences Of Stock:

How To Invest In Pacific Details

Is Pacific Stock a good investment? Details

What is Pacific Biosciences' Net Worth? Details

Largest Life Sciences Tools & Services Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details